Literature DB >> 23196875

Variants in the 15q25 gene cluster are associated with risk for schizophrenia and bipolar disorder.

Kia J Jackson1, Ayman H Fanous, Jingchun Chen, Kenneth S Kendler, Xiangning Chen.   

Abstract

BACKGROUND: Rates of tobacco smoking are significantly higher in patients with schizophrenia compared with the general population. The underlying mechanism for this comorbidity is unclear. One hypothesis is that there are common genetic factors that predispose to both nicotine dependence (ND) and schizophrenia. To investigate this hypothesis, we examined the association of the 15q25 gene cluster, the most significant candidate region to date implicated in ND and smoking behavior, with schizophrenia and bipolar disorder.
METHODS: Five variants in the 15q25 gene cluster (rs951266, rs16969968, rs1051730, rs8040868, and rs17477223) were selected to test for association with schizophrenia diagnosis, bipolar disorder diagnosis, and the presence of negative symptoms of schizophrenia. Effects of the variants on 15q25 gene expression were analyzed using publically available postmortem brain expression data.
RESULTS: A meta-analysis revealed four markers associated with risk for schizophrenia and bipolar disorder (rs951266, rs16969968, rs8040868, and rs17477223), and with the presence of negative symptoms of schizophrenia (rs951266, rs1051730, rs8040868, and rs17477223). The associations were in the same direction as that found for ND. Gene expression analysis indicated an association between genotypes of the rs1051730 variant and CHRNA5 expression in brain and peripheral blood mononuclear cells, and with the rs16969968 and rs17477223 variants in brain.
CONCLUSION: Variants in the 15q25 gene cluster are associated with risk for schizophrenia/bipolar illness, negative symptoms of schizophrenia, and influence CHRNA5 expression in the brain and peripheral blood mononuclear cells. These results are consistent with the notion that there are genetic mechanisms common to schizophrenia, ND, and bipolar disorder.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23196875      PMCID: PMC3644701          DOI: 10.1097/YPG.0b013e32835bd5f1

Source DB:  PubMed          Journal:  Psychiatr Genet        ISSN: 0955-8829            Impact factor:   2.458


  55 in total

1.  Variation in nicotinic acetylcholine receptor genes is associated with multiple substance dependence phenotypes.

Authors:  Richard Sherva; Henry R Kranzler; Yi Yu; Mark W Logue; James Poling; Albert J Arias; Raymond F Anton; David Oslin; Lindsay A Farrer; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2010-05-19       Impact factor: 7.853

2.  A CHRNA5 allele related to nicotine addiction and schizophrenia.

Authors:  L E Hong; X Yang; I Wonodi; C A Hodgkinson; D Goldman; O C Stine; E S Stein; G K Thaker
Journal:  Genes Brain Behav       Date:  2011-04-06       Impact factor: 3.449

3.  Nicotine and familial vulnerability to schizophrenia: a discordant twin study.

Authors:  Michael J Lyons; Jessica L Bar; William S Kremen; Rosemary Toomey; Seth A Eisen; Jack Goldberg; Stephen V Faraone; Ming Tsuang
Journal:  J Abnorm Psychol       Date:  2002-11

4.  Genome-wide meta-analyses identify multiple loci associated with smoking behavior.

Authors: 
Journal:  Nat Genet       Date:  2010-04-25       Impact factor: 38.330

5.  Genomewide association for schizophrenia in the CATIE study: results of stage 1.

Authors:  P F Sullivan; D Lin; J-Y Tzeng; E van den Oord; D Perkins; T S Stroup; M Wagner; S Lee; F A Wright; F Zou; W Liu; A M Downing; J Lieberman; S L Close
Journal:  Mol Psychiatry       Date:  2008-03-18       Impact factor: 15.992

6.  Substance abuse in psychotic disorders: associations with affective syndromes. DSM-IV Field Trial Work Group.

Authors:  S M Strakowski; M Tohen; M Flaum; X Amador
Journal:  Schizophr Res       Date:  1994-12       Impact factor: 4.939

7.  Association and interaction analysis of variants in CHRNA5/CHRNA3/CHRNB4 gene cluster with nicotine dependence in African and European Americans.

Authors:  Ming D Li; Qing Xu; Xiang-Yang Lou; Thomas J Payne; Tianhua Niu; Jennie Z Ma
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-04-05       Impact factor: 3.568

Review 8.  Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings.

Authors:  G W Dalack; D J Healy; J H Meador-Woodruff
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

9.  The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample.

Authors:  Brien Riley; Po-Hsiu Kuo; Brion S Maher; Ayman H Fanous; Jingchun Sun; Brandon Wormley; F Anthony O'Neill; Dermot Walsh; Zhongming Zhao; Kenneth S Kendler
Journal:  Schizophr Res       Date:  2009-10-02       Impact factor: 4.939

10.  Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia.

Authors:  Cathryn M Lewis; Douglas F Levinson; Lesley H Wise; Lynn E DeLisi; Richard E Straub; Iiris Hovatta; Nigel M Williams; Sibylle G Schwab; Ann E Pulver; Stephen V Faraone; Linda M Brzustowicz; Charles A Kaufmann; David L Garver; Hugh M D Gurling; Eva Lindholm; Hilary Coon; Hans W Moises; William Byerley; Sarah H Shaw; Andrea Mesen; Robin Sherrington; F Anthony O'Neill; Dermot Walsh; Kenneth S Kendler; Jesper Ekelund; Tiina Paunio; Jouko Lönnqvist; Leena Peltonen; Michael C O'Donovan; Michael J Owen; Dieter B Wildenauer; Wolfgang Maier; Gerald Nestadt; Jean-Louis Blouin; Stylianos E Antonarakis; Bryan J Mowry; Jeremy M Silverman; Raymond R Crowe; C Robert Cloninger; Ming T Tsuang; Dolores Malaspina; Jill M Harkavy-Friedman; Dragan M Svrakic; Anne S Bassett; Jennifer Holcomb; Gursharan Kalsi; Andrew McQuillin; Jon Brynjolfson; Thordur Sigmundsson; Hannes Petursson; Elena Jazin; Tomas Zoëga; Tomas Helgason
Journal:  Am J Hum Genet       Date:  2003-06-11       Impact factor: 11.025

View more
  18 in total

1.  CHRFAM7A gene expression in schizophrenia: clinical correlates and the effect of antipsychotic treatment.

Authors:  Sunil V Kalmady; Rimjhim Agrawal; Deepthi Venugopal; Venkataram Shivakumar; Anekal C Amaresha; Sri Mahavir Agarwal; Manjula Subbanna; Ashwini Rajasekaran; Janardhanan C Narayanaswamy; Monojit Debnath; Ganesan Venkatasubramanian
Journal:  J Neural Transm (Vienna)       Date:  2018-01-05       Impact factor: 3.575

Review 2.  Negative affective states and cognitive impairments in nicotine dependence.

Authors:  F Scott Hall; Andre Der-Avakian; Thomas J Gould; Athina Markou; Mohammed Shoaib; Jared W Young
Journal:  Neurosci Biobehav Rev       Date:  2015-06-06       Impact factor: 8.989

Review 3.  Human Genetics of Addiction: New Insights and Future Directions.

Authors:  Dana B Hancock; Christina A Markunas; Laura J Bierut; Eric O Johnson
Journal:  Curr Psychiatry Rep       Date:  2018-03-05       Impact factor: 5.285

4.  Nicotine dependence is associated with depression and childhood trauma in smokers with schizophrenia: results from the FACE-SZ dataset.

Authors:  Romain Rey; Thierry D'Amato; Laurent Boyer; Lore Brunel; Bruno Aouizerate; Fabrice Berna; Delphine Capdevielle; Isabelle Chereau; Gabrielle Chesnoy-Servanin; Hélène Denizot; Jean-Michel Dorey; Caroline Dubertret; Julien Dubreucq; Catherine Faget; Franck Gabayet; Christophe Lancon; Jasmina Mallet; David Misdrahi; Christine Passerieux; Aurélie Schandrin; Franck Schürhoff; Mathieu Urbach; Pierre Vidailhet; Pierre-Michel Llorca; Guillaume Fond
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2017-04-07       Impact factor: 5.270

5.  Promoter IV-BDNF deficiency disturbs cholinergic gene expression of CHRNA5, CHRM2, and CHRM5: effects of drug and environmental treatments.

Authors:  Kazuko Sakata; Abigail E Overacre
Journal:  J Neurochem       Date:  2017-08-16       Impact factor: 5.372

Review 6.  Nicotinic acetylcholine receptors in attention circuitry: the role of layer VI neurons of prefrontal cortex.

Authors:  Eliane Proulx; Matthew Piva; Michael K Tian; Craig D C Bailey; Evelyn K Lambe
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

7.  Genetic Relationship between Schizophrenia and Nicotine Dependence.

Authors:  Jingchun Chen; Silviu-Alin Bacanu; Hui Yu; Zhongming Zhao; Peilin Jia; Kenneth S Kendler; Henry R Kranzler; Joel Gelernter; Lindsay Farrer; Camelia Minica; Rene Pool; Yuri Milaneschi; Dorret I Boomsma; Brenda W J H Penninx; Rachel F Tyndale; Jennifer J Ware; Jacqueline M Vink; Jaakko Kaprio; Marcus Munafò; Xiangning Chen
Journal:  Sci Rep       Date:  2016-05-10       Impact factor: 4.379

8.  The Intergenerational Transmission of Developmental Nicotine Exposure-Induced Neurodevelopmental Disorder-Like Phenotypes is Modulated by the Chrna5 D397N Polymorphism in Adolescent Mice.

Authors:  Jordan M Buck; Heidi C O'Neill; Jerry A Stitzel
Journal:  Behav Genet       Date:  2021-06-23       Impact factor: 2.805

9.  DRD2/CHRNA5 interaction on prefrontal biology and physiology during working memory.

Authors:  Annabella Di Giorgio; Ryan M Smith; Leonardo Fazio; Enrico D'Ambrosio; Barbara Gelao; Aldo Tomasicchio; Pierluigi Selvaggi; Paolo Taurisano; Tiziana Quarto; Rita Masellis; Antonio Rampino; Grazia Caforio; Teresa Popolizio; Giuseppe Blasi; Wolfgang Sadee; Alessandro Bertolino
Journal:  PLoS One       Date:  2014-05-12       Impact factor: 3.240

10.  Association between two CHRNA3 variants and susceptibility of lung cancer: a meta-analysis.

Authors:  Xiao Qu; Kai Wang; Wei Dong; Hongchang Shen; Ying Wang; Qi Liu; Jiajun Du
Journal:  Sci Rep       Date:  2016-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.